Aberdeen Wealth Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,040
| Closed | -$697K | – | 166 |
|
|
2025
Q1 | $697K | Buy |
10,040
+60
| +0.6% | +$4.17K | 0.48% | 64 |
|
|
2024
Q4 | $858K | Hold |
9,980
| – | – | 0.59% | 43 |
|
|
2024
Q3 | $1.19M | Sell |
9,980
-850
| -8% | -$101K | 0.78% | 34 |
|
|
2024
Q2 | $1.55M | Hold |
10,830
| – | – | 1.05% | 23 |
|
|
2024
Q1 | $1.39M | Hold |
10,830
| – | – | 0.81% | 33 |
|
|
2023
Q4 | $1.12M | Hold |
10,830
| – | – | 0.81% | 33 |
|
|
2023
Q3 | $985K | Hold |
10,830
| – | – | 0.74% | 37 |
|
|
2023
Q2 | $876K | Hold |
10,830
| – | – | 0.63% | 40 |
|
|
2023
Q1 | $862K | Sell |
10,830
-270
| -2% | -$21.5K | 0.64% | 41 |
|
|
2022
Q4 | $751K | Hold |
11,100
| – | – | 0.57% | 49 |
|
|
2022
Q3 | $553K | Hold |
11,100
| – | – | 0.49% | 61 |
|
|
2022
Q2 | $618K | Sell |
11,100
-600
| -5% | -$33.4K | 0.49% | 57 |
|
|
2022
Q1 | $650K | Hold |
11,700
| – | – | 0.44% | 68 |
|
|
2021
Q4 | $655K | Sell |
11,700
-250
| -2% | -$14K | 0.43% | 66 |
|
|
2021
Q3 | $574K | Sell |
11,950
-100
| -0.8% | -$4.8K | 0.56% | 61 |
|
|
2021
Q2 | $505K | Hold |
12,050
| – | – | 0.47% | 72 |
|
|
2021
Q1 | $406K | Hold |
12,050
| – | – | 0.32% | 95 |
|
|
2020
Q4 | $421K | Hold |
12,050
| – | – | 0.32% | 84 |
|
|
2020
Q3 | $418K | Sell |
12,050
-1,808
| -13% | -$62.7K | 0.4% | 74 |
|
|
2020
Q2 | $454K | Buy |
13,858
+1,638
| +13% | +$53.7K | 0.49% | 70 |
|
|
2020
Q1 | $368K | Hold |
12,220
| – | – | 0.45% | 70 |
|
|
2019
Q4 | $354K | Buy |
+12,220
| New | +$354K | 0.26% | 97 |
|